10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2021-05-17 (Q1 2021) | Holdings: 82 | Value: $6.6B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | Add 9% ($70.5M) | 12.46% | $826.4M | +31.52% | -11.44% | -36.30% | |
| NVAX - NOVAVAX INC | Reduce 21% $(142.6M) | 8.21% | $544.3M | -95.02% | +61.80% | -62.86% | |
| VOR - VOR BIOPHARMA INC | New Purchase | 7.23% | $479.3M | -98.84% | -27.31% | -78.13% | |
| AVIR - ATEA PHARMACEUTICALS INC | 5.00% | $331.5M | -86.49% | +23.72% | -69.76% | ||
| FMTX - FORMA THERAPEUTICS HLDGS INC | 3.81% | $252.5M | -19.88% | -78.06% | |||
| TGTX - TG THERAPEUTICS INC | Reduce 47% $(195.2M) | 3.37% | $223.5M | +14.74% | -35.04% | -82.19% | |
| NKTX - NKARTA INC | 2.78% | $184.4M | -93.54% | +24.10% | -53.85% | ||
| CCXI - CHEMOCENTRYX INC | Reduce 26% $(62.5M) | 2.75% | $182.3M | +39.72% | +110.28% | ||
| MGNX - MACROGENICS INC | Add 13% ($17.8M) | 2.37% | $157.1M | -95.28% | -28.27% | -87.23% | |
| ITOS - ITEOS THERAPEUTICS INC | 2.28% | $151.0M | -59.20% | -0.16% | -32.18% | ||
| IMGN - IMMUNOGEN INC | 2.25% | $149.2M | -22.95% | -47.76% | |||
| TVTX - TRAVERE THERAPEUTICS INC | Add 23% ($26.4M) | 2.11% | $140.2M | -20.26% | +9.10% | +35.70% | |
| TIL - INSTIL BIO INC | New Purchase | 1.84% | $122.2M | -92.27% | -18.14% | -63.86% | |
| PHAT - PHATHOM PHARMACEUTICALS INC | Reduce 19% $(26.7M) | 1.76% | $117.0M | -86.10% | -7.53% | -73.47% | |
| ETNB - 89BIO INC | 1.69% | $112.2M | -54.27% | -18.04% | -86.41% | ||
| KNTE - KINNATE BIOPHARMA INC | 1.69% | $112.0M | -22.17% | -57.03% | |||
| RYTM - RHYTHM PHARMACEUTICALS INC | Add 17% ($14.7M) | 1.56% | $103.6M | +191.61% | -44.70% | -86.12% | |
| ZGNX - ZOGENIX INC | Reduce 1% $(1.2M) | 1.56% | $103.1M | -28.47% | |||
| AXSM - AXSOME THERAPEUTICS INC | 1.41% | $93.7M | +86.67% | -65.76% | -47.49% | ||
| RCKT - ROCKET PHARMACEUTICALS INC COM | Reduce 1% $(1.3M) | 1.41% | $93.5M | -93.08% | -28.44% | -75.18% | |
| ADVM - ADVERUM BIOTECHNOLOGIES INC | Reduce 1% $(1.3M) | 1.39% | $92.3M | -93.31% | -38.95% | -76.98% | |
| EWTX - EDGEWISE THERAPEUTICS INC | New Purchase | 1.28% | $84.9M | -43.97% | -39.85% | -72.55% | |
| CRIS - CURIS INC | Reduce 7% $(6.4M) | 1.22% | $80.8M | -99.20% | -51.11% | -94.75% | |
| BOLT - BOLT BIOTHERAPEUTICS INC | New Purchase | 1.18% | $78.3M | -98.40% | -29.45% | -91.58% | |
| PCVX - VAXCYTE INC | Add 4% ($3.1M) | 1.15% | $76.3M | +81.06% | +19.61% | +25.03% | |
| MCRB - SERES THERAPEUTICS INC | New Purchase | 1.15% | $76.1M | -98.36% | -71.61% | -84.95% | |
| SPRY - SILVERBACK THERAPEUTICS INC | 1.15% | $76.0M | |||||
| IGMS - IGM BIOSCIENCES INC | 1.14% | $75.4M | -98.20% | +9.22% | -76.01% | ||
| KALA - KALA PHARMACEUTICALS INC | 1.11% | $73.3M | -98.43% | -46.05% | -86.86% | ||
| OLMA - OLEMA PHARMACEUTICALS INC | 1.08% | $71.3M | -82.79% | +6.09% | -91.41% | ||
| ORTX - ORCHARD THERAPEUTICS PLC | 1.04% | $69.2M | -52.32% | -91.10% | |||
| SLDB - SOLID BIOSCIENCES INC | Add 24% ($13.2M) | 1.03% | $68.4M | -92.00% | -27.12% | -84.54% | |
| DSGN - DESIGN THERAPEUTICS INC | New Purchase | 0.99% | $65.4M | -82.87% | -33.62% | -52.85% | |
| BDTX - BLACK DIAMOND THERAPEUTICS INC | 0.95% | $62.8M | -90.27% | -64.35% | -92.92% | ||
| TRIL - TRILLIUM THERAPEUTICS INC | 0.86% | $56.8M | -28.00% | ||||
| PMVP - PMV PHARMACEUTICALS INC | 0.85% | $56.3M | -97.12% | -1.49% | -58.35% | ||
| CNTB - CONNECT BIOPHARMA HLDGS LTD | New Purchase | 0.83% | $55.3M | -95.08% | +50.32% | -94.62% | |
| CNST - CONSTELLATION PHARMCETICLS INC | Add 21% ($9.0M) | 0.79% | $52.4M | ||||
| CCCC - C4 THERAPEUTICS INC | 0.77% | $51.0M | -95.76% | +15.03% | -81.65% | ||
| STRO - SUTRO BIOPHARMA INC | 0.73% | $48.2M | -95.84% | -6.36% | -76.74% | ||
| GERN - GERON CORP | 0.72% | $47.6M | +8.33% | -13.19% | -9.72% | ||
| WVE - WAVE LIFE SCIENCES LTD | 0.66% | $43.6M | +8.52% | -8.04% | -79.74% | ||
| DYN - DYNE THERAPEUTICS INC | 0.66% | $43.6M | -22.75% | -10.77% | -69.13% | ||
| VRNA - VERONA PHARMA PLC | New Purchase | 0.64% | $42.6M | +1395.45% | +4.55% | -34.27% | |
| ARDX - ARDELYX INC | Reduce 1% $(567.9K) | 0.61% | $40.2M | -46.55% | -79.88% | -90.34% | |
| INZY - INOZYME PHARMA INC | 0.60% | $39.7M | -74.92% | -4.15% | -75.24% | ||
| STSA - SATSUMA PHARMACEUTICALS INC | New Purchase | 0.53% | $35.0M | -3.85% | -39.88% | ||
| RLAY - RELAY THERAPEUTICS INC | 0.52% | $34.6M | -88.77% | +14.04% | -39.04% | ||
| AKUS - AKOUOS INC | 0.48% | $31.6M | -20.05% | -77.10% | |||
| CERE - CEREVEL THERAPEUTICS HLDNG INC | 0.46% | $30.2M | |||||
| ARQT - ARCUTIS BIOTHERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | -47.92% | -20.53% | -22.12% | |
| ARVN - ARVINAS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CRDF - CARDIFF ONCOLOGY INC | Reduce 100% | 0.00% | $0.00 | ||||
| FPRX - FIVE PRIME THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| INBX - INHIBRX INC | Reduce 100% | 0.00% | $0.00 | ||||
| KROS - KEROS THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| LRMR - LARIMAR THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | -53.86% | -0.15% | -81.01% | |
| LEGN - LEGEND BIOTECH CORP | Reduce 100% | 0.00% | $0.00 | +35.06% | +22.47% | +30.59% | |
| PACB - PACIFIC BIOSCIENCES OF CALIFORNIA INC | Reduce 100% | 0.00% | $0.00 | -91.86% | +14.06% | -77.76% | |